Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during Acute/Early HIV-1 infection

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Rosenberg, Eric S ^a   Graham, Barney S ^b   Chan, Ellen S ^c   Bosch, Ronald J ^c   Stocker, Vicki ^d   Maenza, Janine ^e   Markowitz, Martin ^f   Little, Susan ^g   Sax, Paul E ^h   Collier, Ann C ^e   Nabel, Gary ^b   Saindon, Suzanne ^a   Flynn, Theresa ^a   Kuritzkes, Daniel ^h   Barouch, Dan H ⁱ  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d SOCIAL AND SCIENTIFIC SYSTEMS INC   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f ROCKEFELLER UNIVERSITY   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PLACEBO; VIRUS RNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DNA IMMUNIZATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOGENICITY; MALE; OUTCOME ASSESSMENT; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VIRUS LOAD;

ACUTE DISEASE; ADULT; AIDS VACCINES; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; RNA, VIRAL; VACCINATION; VACCINES, DNA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77954637904     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010555     Document Type: Article

References (10)

1. Palella FJ, Jr., Delaney KM, Moorman AC, Loveless MO, Fuhrer J, et al. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338: 853-860.
2. Graham BS, Koup RA, Roederer M, Bailer RT, Enama ME, et al. (2006) Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine. J Infect Dis 194: 1650-1660.
3. Kassutto S, Maghsoudi K, Johnston MN, Robbins GK, Burgett NC, et al. (2006) Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infection. Clin Infect Dis 42: 1024-1031.
4. Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, et al. (1997) Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278: 1447-1450.
5. Rosenberg ES, Altfeld M, Poon SH, Phillips MN, Wilkes BM, et al. (2000) Immune control of HIV-1 after early treatment of acute infection. Nature 407: 523-526.
6. Kutzler MA, Jacobson JM (2008) Treatment interruption as a tool to measure changes in immunologic response to HIV-1. Curr Opin HIV AIDS 3: 131-135.
7. El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, et al. (2006) CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 355: 2283-2296.
8. Lyles RH, Munoz A, Yamashita TE, Bazmi H, Detels R, et al. (2000) Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J Infect Dis 181: 872-880.
9. Volberding P, Demeter L, Bosch RJ, Aga E, Pettinelli C, et al. (2009) Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment. AIDS 23: 1987-1995.
10. Kaufmann DE, Lichterfeld M, Altfeld M, Addo MM, Johnston MN, et al. (2004) Limited durability of viral control following treated acute HIV infection. PLoS Med 1: e36.